Funder: Alzheimer's Drug Discovery Foundation
Due Dates (Anticipated): June 2026 (Letter of Intent) | September 2026 (Full application)
Funding Amounts: Exploratory: up to ~$250,000; Proof-of-principle: up to $500,000; Validation: larger awards possible, all based on project scope.
Summary: Supports research on peripheral biomarkers for Alzheimer's and related dementias, offering funding, expert consultation, and access to high-quality clinical samples.